The survival prognosis of patients with prostate cancer is closely related to the stage and malignancy of the prostate cancer, and directly related to the treatment taken.
For example, most patients with early-stage prostate cancer can survive up to 10 years after radical surgery, and radical radiation therapy can be effective for patients with early-stage prostate cancer who cannot have surgery for various reasons.
But if left untreated, most patients will die of prostate cancer within 10 years, even if the diagnosis is early.
For patients with intermediate to advanced disease, it is still possible to control the progression and prolong survival with endocrine therapy and other modalities, with a 5-year survival rate of up to 60%.
So prostate cancer is not an incurable disease, and with the advent of new drugs and advances in medical technology, the survival rate for prostate cancer patients will continue to improve.
Related Q&A: